imiquimod has been researched along with HIV Infections in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (5.26) | 18.2507 |
2000's | 20 (35.09) | 29.6817 |
2010's | 28 (49.12) | 24.3611 |
2020's | 6 (10.53) | 2.80 |
Authors | Studies |
---|---|
Bhari, N; Gupta, S; Sindhuja, T | 1 |
Deng, L; Dickson, MA; Gu, L; Kurtansky, N; Lezcano, C; Lin, E; Liu, S; Markova, A; Neumann, NM; Noor, S; Pulitzer, M; Rossi, A; Stoll, J; Yang, N | 1 |
Bastida, C; Blanco, JL; Cranston, RD; Fuertes, I; Lopez-Cabezas, C; Mallolas, J; Ordi, J; Rodríguez-Carunchio, L | 1 |
Barroso Dos Reis, HL; Campos, LG; da Silva Campos, LC; Jacomele Caldas, JV; Miranda, AE; Pedras Almeida, SL; Salume Costa, FL; Tosato Boldrini, NA | 1 |
Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U | 1 |
Cavassini, M; Hoschler, K; Manuel, O; Mombelli, M; Pascual, M | 1 |
Moore, S; Rady, P; Tyring, S | 1 |
Baldelli, F; Cavazzoni, E; Leo, CA; Santorelli, C | 1 |
Baker, JR; Brand, RM; Cranston, RD; Janocko, L; McGowan, I; Siegel, A | 1 |
Boesecke, C; Kalff, JC; Pantelis, D; Rockstroh, J; Schwarze-Zander, C; Stoffels, B; Vilz, TO; Websky, MWV; Wesselmann, PC | 1 |
Clotet, B; García-Cuyás, F; Ornelas, A; Piñol, M; Revollo, B; Sirera, G; Vela, S; Videla, S | 1 |
de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ | 1 |
Hugh, JM; Nijhawan, RI; Osei-Tutu, A | 1 |
Dosekun, O; Farrugia, P; Lewis, F; Sethi, G | 1 |
Bravo, AI; Castro-Perez, GA; Mazzuoccolo, LD; Sorin, I | 1 |
Browne, R; McKendry, A; Narayana, S | 1 |
Chong, WS; Lim, JH; Lim, KS | 1 |
González-González, JG; González-Saldivar, G; Rodarte-Shade, M; Rodríguez-Gutiérrez, R | 1 |
Chirachanakul, P; Jiamton, S; Leeyaphan, C; Omcharoen, V; Prasertworonun, N; Punyaratabandhu, P; Surawan, TM | 1 |
Curto-Barredo, L; Deza, G; Martin-Ezquerra, G; Pujol, RM; Villar García, J | 1 |
Acharya, S; Arumainayagam, JT; Dhesi, I; Kasparis, C; Lau, C | 1 |
Dunne, EF; Introcaso, C; Park, IU | 1 |
Delforge, M; DeWit, S; Feoli, F; Libois, A; Nkuize, M; Willems, N | 1 |
Sharma, DP; Singh, J; Sinha, S; Tandon, S | 1 |
Kaul, R; Yudin, MH | 1 |
Alessi, E; Arancio, L; Cusini, M; Gaiani, F; Ramoni, S | 1 |
Mahto, M; Nathan, M; O'Mahony, C | 1 |
Lee, PK; Wilkins, KB | 1 |
Biasin, M; Borelli, M; Clerici, M; Lo Caputo, S; Mazzotta, F; Naddeo, V; Piacentini, L; Pierotti, P; Shearer, GM; Trabattoni, D | 1 |
Bercovitch, L; Lee, KC; Risser, J | 1 |
Barton, SE; Bower, M; Dixon, G; Fox, PA; Francis, N; Nathan, M; Singh, N; Weir, J | 1 |
Agut, H; Caumes, E; Challine, D; Deback, C; Lascaux, AS; Lévy, Y; Melica, G | 1 |
Kaushal, S; Kopparthy, P; Merideth, M; Pulanic, TK; Stratton, P | 1 |
Hirokawa, D; Lee, SN; Samie, F; Woldow, A | 1 |
He, Q; Introcaso, CE; Kovarik, CL; Rady, PL; Tyring, SK | 1 |
Fox, PA | 1 |
Bourgault-Villada, I; Pavlovic, M; Roudier-Pujol, C; Saiag, P | 1 |
Beyeler, M; Burg, G; Dummer, R; Morcinek, J | 1 |
Johnson, R; Stockfleth, E | 1 |
Alessi, E; Carminati, G; Cusini, M; Franchi, C; Locatelli, A; Salmaso, F; Vernaci, C; Zerboni, R | 1 |
Altmeyer, P; Brockmeyer, NH; Conant, MA; Hochdorfer, B; Kreuter, A; Stücker, M; Weiland, U | 1 |
Aubin, F; Drobacheff-Thiebaut, C; Laurent, R; Mougin, C; Pelletier, F; Venier, AG | 1 |
Costa, RR; de Freitas, VG; de Góis, NM; Kesselring, F; Kobata, MP; Ribalta, JC; Taha, NS | 1 |
Altmeyer, P; Brockmeyer, NH; Kreuter, A; Pfister, H; Wafaisade, A; Weissenborn, SJ; Wieland, U | 1 |
Bower, M; Dancey, G; Stebbing, J | 1 |
Rosen, T | 1 |
Altmeyer, P; Brockmeyer, NH; Hochdorfer, B; Kreuter, A; Pfister, H; Stücker, M; Swoboda, J; Weissenborn, SJ; Wieland, U | 1 |
Abbo, L; Dickinson, G; Doblecki, S; Haslett, PA; Shrestha, N; Vincek, V | 1 |
Correa, LA; Gaviria, A; Herrera, S; Sanclemente, G; Tyring, SK; Wolff, JC | 1 |
Altmeyer, P; Brockmeyer, NH; Gambichler, T; Kreuter, A; Pfister, H; Potthoff, A; Stücker, M; Swoboda, J; Wieland, U | 1 |
Cooper, DA; Couldwell, D; Cunningham, P; Goldstein, D; Hertzog, P; McCarville, S; Newell, M; Owens, M; Parrish, S; Tomkinson, E | 1 |
Conant, MA; Friedman-Kien, AE; Gilson, RJ; Nayagam, AT; Owens, ML; Pietig, DC; Shupack, JL; Smith, MH; Swann, RV; Weber, JN | 1 |
Pehoushek, J; Smith, KJ | 1 |
Smart, T | 1 |
Allan, PS; Das, S; Wade, AA | 1 |
9 review(s) available for imiquimod and HIV Infections
Article | Year |
---|---|
Asian guidelines for condyloma acuminatum.
Topics: Adult; Antiviral Agents; Child; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines | 2022 |
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
Topics: Acitretin; Cidofovir; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Mycophenolic Acid; Papillomaviridae; Papillomavirus Infections; Vaccines | 2022 |
Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Topics: Adolescent; Aminoquinolines; Antiviral Agents; Anus Neoplasms; Centers for Disease Control and Prevention, U.S.; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines; Practice Guidelines as Topic; Prevalence; United States; Young Adult | 2015 |
More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Vulvar Neoplasms | 2010 |
Condyloma and other infections including human immunodeficiency virus.
Topics: Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Anus Neoplasms; Chancroid; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Imiquimod; Male; Penicillin G; Proctitis; Rectal Diseases; Sexually Transmitted Diseases; Syphilis; Ulcer | 2010 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cidofovir; Comorbidity; Cytosine; Female; Fluorouracil; Global Health; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Incidence; Male; Organophosphonates; Papillomavirus Infections; Precancerous Conditions; Trichloroacetic Acid | 2012 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors | 2003 |
Imiquimod 5% cream for the treatment of cutaneous lesions in immunocompromised patients.
Topics: Adjuvants, Immunologic; Aminoquinolines; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Organ Transplantation; Skin Diseases | 2003 |
8 trial(s) available for imiquimod and HIV Infections
Article | Year |
---|---|
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial.
Topics: Antibodies, Viral; Hemagglutination Inhibition Tests; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Influenza Vaccines; Influenza, Human; Injections, Intramuscular; Seasons; Vaccines, Inactivated | 2021 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Netherlands; Papillomaviridae; Prospective Studies | 2013 |
A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Carcinoma, Squamous Cell; Double-Blind Method; HIV Infections; HIV-1; Homosexuality, Male; Humans; Imiquimod; Male | 2010 |
[Effects of imiquimod on latent human papillomavirus anal infection in HIV-infected patients].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminoquinolines; Anus Diseases; Anus Neoplasms; Carcinoma; Double-Blind Method; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Prospective Studies; Risk Factors | 2004 |
Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; DNA, Viral; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; Suppositories; Treatment Outcome | 2006 |
Effect of imiquimod in anogenital warts from HIV-positive men.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; Genital Diseases, Male; HIV Infections; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Secondary Prevention; Treatment Outcome | 2007 |
Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification.
Topics: Administration, Oral; Adult; Aminoquinolines; beta 2-Microglobulin; Female; HIV; HIV Infections; Humans; Imiquimod; Interferon Inducers; Interferons; Male; Middle Aged | 1998 |
A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; CD4 Lymphocyte Count; Condylomata Acuminata; Double-Blind Method; Drug Eruptions; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Safety | 1999 |
40 other study(ies) available for imiquimod and HIV Infections
Article | Year |
---|---|
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma.
Topics: Cryotherapy; Female; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Immunotherapy; Male; Middle Aged; Sarcoma, Kaposi; Sexual and Gender Minorities; Skin Neoplasms | 2023 |
The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals.
Topics: Adjuvants, Immunologic; Administration, Rectal; Anal Canal; Anus Neoplasms; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Squamous Intraepithelial Lesions; Suppositories; Treatment Outcome; Warts | 2019 |
Hypertrophic genital herpes in an HIV-infected female patient: Imiquimod as an alternative treatment.
Topics: Antiviral Agents; Coinfection; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Middle Aged; Ulcer; Vulva | 2020 |
Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients.
Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Italy; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2017 |
A Pilot Study of the Immunologic, Virologic, and Pathologic Consequences of Intra-anal 5% Imiquimod in HIV-1-Infected Men With High-Grade Squamous Intraepithelial Lesions.
Topics: Adult; Aminoquinolines; Anal Canal; Anus Neoplasms; Carcinoma in Situ; Cytokines; HIV Infections; HIV-1; Humans; Imiquimod; Male; Papillomavirus Infections; Pilot Projects; Prospective Studies | 2018 |
[Treatment of HPV-associated Anal Lesions in HIV-positive Patients - Comparison of Surgical Treatment and Topical Therapy with Imiquimod].
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; HIV; HIV Infections; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Retrospective Studies | 2019 |
Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Retroviral Agents; Anus Diseases; Condylomata Acuminata; Electrosurgery; Genotype; HIV Infections; Homosexuality, Male; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Infrared Rays; Male; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Sustained clinical resolution of acquired epidermodysplasia verruciformis in an immunocompromised patient after discontinuation of oral acitretin with topical imiquimod.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Cutaneous; Administration, Oral; Aminoquinolines; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Keratolytic Agents; Male; Middle Aged; Treatment Outcome | 2013 |
Vulval disease in HIV-positive women attending a tertiary vulval dermatology clinic over a five-year period.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Diseases | 2013 |
Acquired epidermodysplasia verruciformis in a patient with congenital HIV infection.
Topics: Aminoquinolines; Antiretroviral Therapy, Highly Active; Biopsy; Cryosurgery; Electrocoagulation; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Keratinocytes; Male; Tretinoin; Young Adult | 2013 |
Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
Topics: Acyclovir; Adult; Aminoquinolines; Antiviral Agents; Herpes Genitalis; Herpes Simplex; HIV Infections; HIV-1; HIV-2; Humans; Imiquimod; Male; Polymerase Chain Reaction; Simplexvirus; Treatment Outcome; Ulcer | 2015 |
Dramatic clearance of HIV-associated bowenoid papulosis using combined oral acitretin and topical 5% imiquimod.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Bowen's Disease; Drug Therapy, Combination; HIV Infections; Humans; Imiquimod; Keratolytic Agents; Male; Skin Neoplasms | 2014 |
Buschke-Lowenstein tumor.
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Buschke-Lowenstein Tumor; HIV Infections; Humans; Imiquimod; Male; Skin Neoplasms | 2015 |
Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ulcer | 2015 |
Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged | 2015 |
Acquired epidermodysplasia verruciformis in an HIV-positive patient.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antiretroviral Therapy, Highly Active; Epidermodysplasia Verruciformis; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin; Treatment Outcome | 2016 |
Treatment of anal dysplasia in HIV-positive men who have sex with men in a large AIDS reference centre.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Feasibility Studies; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Immunocompromised Host; Male; Middle Aged; Valacyclovir; Valine | 2017 |
Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Resistance, Viral; Female; Foscarnet; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Hypertrophy; Imiquimod; Treatment Outcome; Vulvar Diseases | 2008 |
Penile intraepithelial carcinoma treated with imiquimod 1% in an HIV-positive patient.
Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Carcinoma in Situ; Cell Transformation, Neoplastic; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; HIV Infections; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Staging; Penile Diseases; Penile Neoplasms; Risk Assessment; Time Factors; Treatment Outcome | 2009 |
TLR activation pathways in HIV-1-exposed seronegative individuals.
Topics: Adaptive Immunity; Aminoquinolines; Cells, Cultured; Chemokine CCL3; Cytokines; Flow Cytometry; HIV Infections; HIV Seronegativity; HIV-1; Humans; Imiquimod; Immunity, Innate; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Poly I-C; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2010 |
What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Antiretroviral Therapy, Highly Active; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Male; Treatment Outcome | 2010 |
Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Topics: Acyclovir; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; HIV-1; Humans; Imiquimod; Lamivudine; Male; Middle Aged; Nelfinavir; Simplexvirus; Zidovudine | 2012 |
Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2012 |
Treatment of recalcitrant herpes simplex virus with topical imiquimod.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Herpes Simplex; HIV Infections; Humans; Imiquimod; Male; Treatment Outcome | 2011 |
Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient.
Topics: Adult; Aminoquinolines; Amputation, Surgical; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA, Viral; Fingers; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Lip Neoplasms; Male; Mohs Surgery; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin Neoplasms | 2012 |
Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Penile Diseases; Treatment Outcome | 2002 |
5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Diseases; Case-Control Studies; Condylomata Acuminata; Drug Administration Schedule; Female; HIV Infections; Humans; Imiquimod; Male; Severity of Illness Index; Treatment Outcome | 2004 |
Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; HIV Infections; Humans; Imiquimod; Male; Ointments | 2004 |
Grade 3 vulvar and anal intraepithelial neoplasia in a HIV seropositive child--therapeutic result: case report.
Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Anus Neoplasms; Carcinoma; Child; Combined Modality Therapy; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; Humans; Imiquimod; Immunocompromised Host; Low-Level Light Therapy; Papillomavirus Infections; Risk Assessment; Treatment Outcome; Vulvar Neoplasms | 2005 |
5% imiquimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; DNA, Viral; Dose-Response Relationship, Drug; Electrocoagulation; Follow-Up Studies; HIV Infections; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Male; Rectal Diseases; Suppositories; Treatment Outcome; Viral Load | 2006 |
A tale of three Hs: HPV, HIV & HAART.
Topics: Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Female; HIV Infections; Humans; Imiquimod; Male; Mass Screening; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Viral Vaccines | 2006 |
Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; HIV Infections; Humans; Imiquimod; Male; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome | 2006 |
Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiviral Agents; Dendritic Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Imiquimod; Interferon Inducers; Male | 2007 |
Immune boosters. Italian study finds immune booster useful against genital warts.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; CD4 Lymphocyte Count; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Italy; Male; Viral Load | 2004 |
Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.
Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; DNA, Viral; Follow-Up Studies; HIV Infections; Human papillomavirus 16; Human papillomavirus 18; Humans; Imiquimod; Longitudinal Studies; Male; Papillomaviridae; Prospective Studies; Treatment Outcome | 2008 |
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; HIV Infections; HIV-1; Humans; Imiquimod; Male; Middle Aged | 2001 |
International Congress on Chemotherapy.
Topics: Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Aminoquinolines; Anti-Bacterial Agents; Anti-Infective Agents; Antiviral Agents; Condylomata Acuminata; Cryptosporidiosis; Drug Carriers; Exonucleases; Foscarnet; HIV Infections; HIV Protease Inhibitors; Humans; Imiquimod; Liposomes; Roxithromycin | 1995 |
Immune booster used to fight drug-resistant herpes.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Microbial; Herpes Genitalis; HIV Infections; Humans; Imiquimod; Male | 2001 |
Imiquimod and HIV transmission.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Disease Transmission, Infectious; HIV Infections; HIV-1; Humans; Imiquimod; Warts | 2002 |